Iris Biotech specialise in Reagents for Life Sciences, supplying Compounds & Consumables for Peptide Chemistry, Drug Delivery, and Custom Syntheses
Founded in 2001, Iris Biotech provides scientists in both industry and academia with innovative and rare compounds, while also being your reliable partner for a comprehensive supply of standard consumables. We’re dedicated to deliver competent service as well as the highest quality to our customers.
Our mission is to accompany our customers in their current projects by supplying the most novel substances and latest technologies.
Iris Biotech supplies Amino Acids, Resins, Reagents and Solvents. Besides that, we also offer a great variety of substances for Drug Delivery, such as PEGs, both in monodisperse and in polydisperse forms, as well as various poly(amino acids), which are biodegradable alternatives to PEGs. Both PEGs and poly(amino acids) are a popular tool for researchers to improve the solubility and pharmacokinetic properties of peptides, proteins, biopharmaceuticals and organic drug molecules.
Reagents for Life Sciences and Diagnostics
A smaller but nonetheless important part of our portfolio, the Life Sciences and Diagnostics section encompasses substrates for reporter enzymes and drug interaction studies, metabolites, glucuronides, inhibitors and inducers, antibody conjugates and cross-linkers, natural products with biological and pharmacological activity, carbohydrates, as well as dyes and fluorescent labels that are used as tools in immunology, biochemistry and molecular biology.
Due to the growing demand for tailor-made compounds and solutions, we further increased our Custom Synthesis capabilities in 2013. Our skilled scientists and technicians offer profound expertise in the custom manufacturing of complex compounds, such as rare chiral building blocks, sophisticated orthogonal protecting groups, heterocycles, PEGs and PEG-analogues.
Empowering Peptide Innovation
With this guiding theme in mind, Iris Biotech attends various conferences, symposia and exhibitions each year, which allows us to remain in direct contact with scientists from academia and industry alike, in order to exchange knowledge, and to gather new ideas to tackle your current challenges.